Summary
Trimethoprim-sulfamethoxazole (co-trimoxazole) is used extensively for treatment of pulmonary and urinary tract infections. Side effects may affect skin, blood, bone marrow, kidney and the liver. Although a number of sulfonamides have been reported to have produced hepatic lesions, hepatitis following therapy with trimethoprim-sulfamethoxazole is a rather rare event. While trimethoprim has not yet been reported as a cause of hepatic disorders, sulfameth-oxazole has occasionally been described as inducing hepatic injury. In some cases, these reactions are accompanied by symptoms indicative for allergic reactions such as fever, rash and eosinophilia. Seven well documented cases are analyzed and discussed with respect to the nature of side effects caused by co-trimoxazole.
Zusammenfassung
Trimethoprim-Sulfamethoxazol (Co-trimoxazol) findet in erster Linie bei Infektionen des Pulmonal- und Urogenitaltrakts Anwendung. Nebenwirkungen können vor allem an der Haut, aber auch im peripheren Blutbild, Knochenmark und der Niere auftreten. Selten dagegen sind Sulfonamid-induzierte Reaktionen an der Leber. Sie traten nach Gabe von Sulfamethoxazol, nicht dagegen von Trimethoprim auf. In dieser kurzen Übersicht werden sieben in der Literatur gut dokumentierte Fälle einer medikamentös-induzierten Hepatitis bei Co-trimoxazol-Therapie beschrieben, die alle die charakteristischen Symptome einer allergischen Reaktion mit Fieber, Ausschlag und Eosinophilie zeigten.
Similar content being viewed by others
Literature
Zimmermann, H. J. Drug hepatotoxicity: spectrum of clinical lesions. In:Davis, M., Tredger, J. M., Williams, R. (eds.): Drug reactions and the liver. Pitman Medical, London 1981, pp. 35–53.
Van Arsdel, P. P. Jr. Allergy and adverse drug reactions. Am. Acad. Dermatol. 6 (1982) 833–845.
Mathews, K. P. Clinical spectrum of allergic and pseudo-allergic drug reactions. J. Allergy Clin. Immunol. 74 (1984) 558–566.
Berg, P. A., Brattig, N., Diao, G.-J., Schuff-Werner, P. Diagnose Arzneimittel-bedingter allergischer Nebenwirkungen mit Hilfe des Lymphozytentransformations-Tests. Allergologie 6 (1983) 77–81.
Stejskal, V. D. M., Olin, R. G., Forsbeck, M. The lymphocyte transformation test for diagnosis of drug-induced occupational allergy. J. Allergy Clin. Immunol. 77 (1986) 411–426.
Goldstein, R. A., Patterson, R. Drug allergy: prevention, diagnosis, and treatment. Ann. Intern. Med. 100 (1984) 302–303.
Griffin, J. P. Drug induced allergic and hypersensitivity reactions. Practitioner 227 (1983) 1283–1297.
Lennon, D. Co-trimoxazole toxicity. Lancet II (1984) 1152.
Medicine Adverse Reaction Committee, 18th Annual Report, 1983.
Fries, J., Siraganian, R. Sulfonamide hepatitis. Report of a case due to sulfamethoxazole and sulfisoxazole. New Engl. J. Med. 274 (1966) 95–97.
Dujovne, C. A., Chan, C. H., Zimmerman, H. J. Sulfonamide hepatic injury. Review of the literature and report of a case due to sulfamethoxazole. N. Engl. J. Med. 277 (1967) 785–788.
Ransohoff, D. F., Jacobs, G. Terminal hepatic failure following a small dose of sulfamethoxazole-trimethoprim. Gastroenterology 80 (1981) 816–819.
Thies, P. W., Dull, W. L. Trimethoprim-sulfamethoxazole-induced cholestatic hepatitis. Arch. Intern. Med. 144 (1984) 1691–1692.
Mair, S. S., Kaplan, J. M., Levine, L. H., Geraci, K. Trimethoprim-sulfamethoxazole-induced intrahepatic cholestasis. Ann. Intern. Med. 92 (1980) 511–512.
Abi-Mansur, P., Ardiaca, M. C., Allam, C., Shammaia, M. Trimethoprim-sulfamethoxazole-induced cholestasis. Am. J. Gastroenterol. 76 (1981) 356–359.
Warrington, R. J., Sauder, P. J., McPhillips, S. Lymphocyte transformation studies in suspected hypersensitivity to trimethoprim-sulphamethoxazole. Clin. Allergy 13 (1983) 235–240.
Kraemer, M. J., Kendall, R., Hickman, R. O., Haas, J. E., Bierman, C. W. A generalized allergic reaction with acute interstitial nephritis following trimethoprim-sulfamethoxazole use. Ann. Allergy 49 (1982) 323–325.
Erdmann, E. Pharmakodynamische Aspekte medikamentöser Wechselwirkungen — Rezeptorbesetzungen und pharmakologische Interaktionen. Internist 20 (1979) 229–237.
Ishizaka, K. Mast cell activation and mediator release. Prog. Allergy 34 (1984) 1–322.
Shear, N. H., Spielberg, S. P., Grant, D. M., Tang, B. K., Kalow, W. Differences in metabolism of sulphonamides predisposing to idiosyncratic toxicity. Ann. Intern. Med. 105 (1986) 179–184.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berg, P.A., Daniel, P.T. Co-trimoxazole-induced hepatic injury — an analysis of cases with hypersensitivity-like reactions. Infection 15 (Suppl 5), S259–S264 (1987). https://doi.org/10.1007/BF01643200
Issue Date:
DOI: https://doi.org/10.1007/BF01643200